ArticleBMC health services research2024
Risk management and empirical study of the doctor-patient relationship: based on 1790 litigation cases of medical damage liability disputes in China.
Article in BMC health services research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The Medicolegal Challenges of Facial Plastic Surgery: A Systematic Review.Aesthetic surgery journal · 2025Pooled it
- Causes, Characteristics, and Risk Factors of Medical Damage Liability Disputes: A 13-Year Retrospective Analysis of 1761 Litigation Cases in Chongqing, China.Healthcare (Basel, Switzerland) · 2026Article
- A Qualitative Comparative Study of the Doctor-Patient Relationship Model and Decision-Making Style among Chinese and Japanese Doctors.Asian bioethics review · 2026Article
- The impact of national comprehensive medical reform on healthcare quality: evidence from China.Frontiers in public health · 2026Article
- Reforming the white coat economy: judicial evidence and institutional implications from China's healthcare anti-corruption campaign.Frontiers in public health · 2026Article
- Practical dilemmas and communication reconstruction of patients' right to informed consent under the Civil Code.Frontiers in public health · 2026Article
- The social justice dilemma of liability allocation in medical damage: a qualitative analysis based on case judgments.Frontiers in public health · 2026Article
- Patient influencing doctor-patient dispute trials: evidence from China.Frontiers in psychology · 2026Article
- Analysis of the causes of improper medical decision-making in medical damage liability disputes in China: a text mining approach.BMC health services research · 2025Article
- Eager for an innovative path: solving the puzzle of medical dispute resolution in China combined with bibliometric analysis.Frontiers in health services · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundCompensation for medical damage liability disputes (CMDLD) seriously hinders the healthy development of hospitals and undermines the harmony of the doctor-patient relationships (DPR). Risk management in the DPR has become an urgent issue of the day. The study aims to provide a comprehensive description of CMDLD in China and explore its influencing factors, and make corresponding recommendations for the management of risks in the DPR.
methodsThis study extracted data from the China Judgment Online - the official judicial search website with the most comprehensive coverage. Statistical analysis of 1,790 litigation cases of medical damage liability disputes (COMDLD) available from 2015 to 2021.
resultsCOMDLD generally tended to increase with the year and was unevenly distributed by regions; the compensation rate was 52.46%, the median compensation was 134,900 yuan and the maximum was 2,234,666 yuan; the results of the single factor analysis showed that there were statistically significant differences between the compensation for different years, regions, treatment attributes, and trial procedures (P < 0.05); the correlation analysis showed that types of hospitals were significantly negatively associated with regions (R=-0.082, P < 0.05); trial procedures were significantly negatively correlated with years (R=-0.484, P < 0.001); compensat- ion was significantly positively correlated with years, regions, and treatment attributes (R = 0.098-0.294, P < 0.001) and negatively correlated with trial procedures (R=-0.090, P < 0.01); regression analysis showed that years, treatment attributes, and regions were the main factors affecting the CMDLD (P < 0.05).
conclusionsYears, regions, treatment attributes, and trial procedures affect the outcome of CMDLD. This paper further puts forward relevant suggestions and countermeasures for the governance of doctor-patient risks based on the empirical results. Including rational allocation of medical resources to narrow the differences between regions; promoting the expansion and sinking of high-quality resources to improve the level of medical services in hospitals at all levels; and developing a third-party negotiation mechanism for medical disputes to reduce the cost of medical litigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.